Anandamide-induced cell death in primary neuronal cultures: role of calpain and caspase pathways

[1]  I. Maruyama,et al.  Anandamide induces cell death independently of cannabinoid receptors or vanilloid receptor 1: possible involvement of lipid rafts , 2003, Cellular and Molecular Life Sciences CMLS.

[2]  D. Owen,et al.  Comparison of effects of anandamide at recombinant and endogenous rat vanilloid receptors. , 2002, British journal of anaesthesia.

[3]  A. Yakovlev,et al.  Ceramide induces neuronal apoptosis through the caspase-9/caspase-3 pathway. , 2002, Biochemical and biophysical research communications.

[4]  R. Giffard,et al.  Caspase inhibitors reduce the apoptotic but not necrotic component of kainate injury in primary murine cortical neuronal cultures , 2002, Neurological research.

[5]  H. Hansen,et al.  Putative neuroprotective actions of N-acyl-ethanolamines. , 2002, Pharmacology & therapeutics.

[6]  Oliver Popp,et al.  Ionomycin-activated Calpain Triggers Apoptosis , 2002, The Journal of Biological Chemistry.

[7]  C. Fowler,et al.  ‘Entourage’ effects of N‐acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide‐induced vanilloid receptor activation and upon anandamide metabolism , 2002, British journal of pharmacology.

[8]  S. Milstien,et al.  Ceramide‐induced cell death in primary neuronal cultures: Upregulation of ceramide levels during neuronal apoptosis , 2002, Journal of neuroscience research.

[9]  E. Fride.  Endocannabinoids in the central nervous system--an overview. , 2002, Prostaglandins, leukotrienes, and essential fatty acids.

[10]  Kevin K W Wang,et al.  Selective release of calpain produced alphalI-spectrin (alpha-fodrin) breakdown products by acute neuronal cell death. , 2002, Biological chemistry.

[11]  A. Finazzi-Agro’,et al.  Endocannabinoids and their actions. , 2002, Vitamins and hormones.

[12]  T. Sugawara,et al.  Evidence of Phosphorylation of Akt and Neuronal Survival after Transient Focal Cerebral Ischemia in Mice , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  C. Fowler,et al.  Inhibition of rat C6 glioma cell proliferation by endogenous and synthetic cannabinoids. Relative involvement of cannabinoid and vanilloid receptors. , 2001, The Journal of pharmacology and experimental therapeutics.

[14]  K. Nicolay,et al.  Exogenous Anandamide Protects Rat Brain against Acute Neuronal Injury In Vivo , 2001, The Journal of Neuroscience.

[15]  S. Ben-Shabat,et al.  An endogenous cannabinoid (2-AG) is neuroprotective after brain injury , 2001, Nature.

[16]  P. Vallet,et al.  Prevention of apoptotic neuronal death by controlling procaspases? A point of view , 2001, Brain Research Reviews.

[17]  A. Yakovlev,et al.  Differential Expression of Apoptotic Protease-Activating Factor-1 and Caspase-3 Genes and Susceptibility to Apoptosis during Brain Development and after Traumatic Brain Injury , 2001, The Journal of Neuroscience.

[18]  V. Sée,et al.  Oxidative Stress Induces Neuronal Death by Recruiting a Protease and Phosphatase-gated Mechanism* , 2001, The Journal of Biological Chemistry.

[19]  J. Manzanares,et al.  Anandamide, but not 2‐arachidonoylglycerol, accumulates during in vivo neurodegeneration , 2001, Journal of neurochemistry.

[20]  M. Iadarola,et al.  Anandamide Activates Vanilloid Receptor 1 (VR1) at Acidic pH in Dorsal Root Ganglia Neurons and Cells Ectopically Expressing VR1* , 2001, The Journal of Biological Chemistry.

[21]  D. Lambert,et al.  Temperature-dependent activation of recombinant rat vanilloid VR1 receptors expressed in HEK293 cells by capsaicin and anandamide. , 2001, European journal of pharmacology.

[22]  A. Finazzi-Agro’,et al.  The Activity of Anandamide at Vanilloid VR1 Receptors Requires Facilitated Transport across the Cell Membrane and Is Limited by Intracellular Metabolism* , 2001, The Journal of Biological Chemistry.

[23]  A. Randall,et al.  Characterisation using FLIPR of human vanilloid VR1 receptor pharmacology. , 2001, European journal of pharmacology.

[24]  C. Fowler,et al.  Characterization of palmitoylethanolamide transport in mouse Neuro‐2a neuroblastoma and rat RBL‐2H3 basophilic leukaemia cells: comparison with anandamide , 2001, British journal of pharmacology.

[25]  Changlian Zhu,et al.  Synergistic Activation of Caspase-3 by m-Calpain after Neonatal Hypoxia-Ischemia , 2001, The Journal of Biological Chemistry.

[26]  J. Gil,et al.  Low concentrations of 1‐methyl‐4‐phenylpyridinium ion induce caspase‐mediated apoptosis in human SH‐SY5Y neuroblastoma cells , 2001, Journal of neuroscience research.

[27]  S. Hansen,et al.  Accumulation of the anandamide precursor and other N‐acylethanolamine phospholipids in infant rat models of in vivo necrotic and apoptotic neuronal death , 2001, Journal of neurochemistry.

[28]  D. Green,et al.  Chapter 16 The (Holey) study of mitochondria in apoptosis , 2001 .

[29]  A. Faden,et al.  mGluR5 antagonists 2-methyl-6-(phenylethynyl)-pyridine and (E)-2-methyl-6-(2-phenylethenyl)-pyridine reduce traumatic neuronal injury in vitro and in vivo by antagonizing N-methyl-D-aspartate receptors. , 2001, The Journal of pharmacology and experimental therapeutics.

[30]  D. Green,et al.  The (Holey) study of mitochondria in apoptosis. , 2001, Methods in cell biology.

[31]  A. Thor,et al.  Reconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin- and etoposide-induced apoptosis. , 2001, Cancer research.

[32]  M. Mezna,et al.  Subtype identification and functional properties of inositol 1,4, 5-trisphosphate receptors in heart and aorta. , 2000, Pharmacological research.

[33]  Honglin Zhou,et al.  Akt Regulates Cell Survival and Apoptosis at a Postmitochondrial Level , 2000, The Journal of cell biology.

[34]  G. Melino,et al.  Anandamide Induces Apoptosis in Human Cells via Vanilloid Receptors , 2000, The Journal of Biological Chemistry.

[35]  C. Fowler,et al.  Differences in the pharmacological properties of rat and chicken brain fatty acid amidohydrolase , 2000, British journal of pharmacology.

[36]  K. Willoughby,et al.  Influence of phenylmethylsulfonyl fluoride on anandamide brain levels and pharmacological effects. , 2000, Life sciences.

[37]  R. Prinjha,et al.  Characterization using FLIPR of rat vanilloid receptor (rVR1) pharmacology , 2000, British journal of pharmacology.

[38]  D. Smart,et al.  Anandamide: an endogenous activator of the vanilloid receptor. , 2000, Trends in pharmacological sciences.

[39]  D. Greenberg,et al.  Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats , 2000, Neuroscience Letters.

[40]  K. Waku,et al.  Evidence That 2-Arachidonoylglycerol but Not N-Palmitoylethanolamine or Anandamide Is the Physiological Ligand for the Cannabinoid CB2 Receptor , 2000, The Journal of Biological Chemistry.

[41]  J. Chambers,et al.  The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1) , 2000, British journal of pharmacology.

[42]  M. Mattson,et al.  Caspase and calpain substrates: Roles in synaptic plasticity and cell death , 1999, Journal of neuroscience research.

[43]  P. Blumberg,et al.  The cloned rat vanilloid receptor VR1 mediates both R-type binding and C-type calcium response in dorsal root ganglion neurons. , 1999, Molecular pharmacology.

[44]  W. Graier,et al.  Anandamide‐induced mobilization of cytosolic Ca2+ in endothelial cells , 1999, British journal of pharmacology.

[45]  R. Pertwee,et al.  Agonist‐inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656 and AM630 , 1999, British journal of pharmacology.

[46]  N. Thornberry,et al.  Inhibition of Human Caspases by Peptide-based and Macromolecular Inhibitors* , 1998, The Journal of Biological Chemistry.

[47]  Eugene M. Johnson,et al.  Evidence of a Novel Event during Neuronal Death Development of Competence-to-Die in Response to Cytoplasmic Cytochrome c , 1998, Neuron.

[48]  B. Pike,et al.  Regional calpain and caspase‐3 proteolysis of α‐spectrin after traumatic brain injury , 1998, Neuroreport.

[49]  Alan G. Porter,et al.  Caspase-3 Is Required for DNA Fragmentation and Morphological Changes Associated with Apoptosis* , 1998, The Journal of Biological Chemistry.

[50]  V. Dixit,et al.  Caspase-9, Bcl-XL, and Apaf-1 Form a Ternary Complex* , 1998, The Journal of Biological Chemistry.

[51]  M. Scanziani,et al.  Dual Effects of Anandamide on NMDA Receptor‐Mediated Responses and Neurotransmission , 1998, Journal of neurochemistry.

[52]  J. Sutcliffe,et al.  Fatty acid amide hydrolase, the degradative enzyme for anandamide and oleamide, has selective distribution in neurons within the rat central nervous system , 1997, Journal of neuroscience research.

[53]  S. Srinivasula,et al.  Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade , 1997, Cell.

[54]  A. Yakovlev,et al.  The Role of CED-3-Related Cysteine Proteases in Apoptosis of Cerebellar Granule Cells , 1997, The Journal of Neuroscience.

[55]  N. Volkow,et al.  123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors. , 1996, European journal of pharmacology.

[56]  K. Mackie,et al.  Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. , 1995, Molecular pharmacology.

[57]  Y. Saito,et al.  Identification and characterization of membrane-bound calpains in clathrin-coated vesicles from bovine brain. , 1995, European journal of biochemistry.

[58]  Keizo Yoshida,et al.  Non-competitive NMDA antagonists, FR115427 and MK801, enhance neuronal survival in primary culture , 1995, Neuroscience Letters.

[59]  A. Leiser,et al.  Oxidative stress aspects of the cytotoxicity of carbamide peroxide: in vitro studies. , 1995, Toxicology letters.

[60]  J. Schwartz,et al.  Formation and inactivation of endogenous cannabinoid anandamide in central neurons , 1994, Nature.

[61]  S. Furukawa,et al.  Etoposide induces programmed death in neurons cultured from the fetal rat central nervous system , 1994, Brain Research.